Bioio
Investors
Venture capital firms, private equity investors, and strategic partners
| Investor | Type |
|---|---|
BioGenerator Ventures | N/A |
Missouri Technology Corporation | Venture Capital |
National Institute of Diabetes and Digestive and Kidney Diseases | N/A |
National Institute of General Medical Sciences | N/A |
quadraScope Ventures | N/A |
Common Investor Types
- •Venture Capital Firms: Early-stage and growth equity investors
- •Private Equity: Later-stage institutional investors
- •Strategic Investors: Corporations in related industries
- •Angel Investors: High-net-worth individuals
- •Family Offices: Private wealth management firms
What Investors Provide
- ✓Capital for growth and expansion
- ✓Strategic guidance and expertise
- ✓Industry connections and partnerships
- ✓Market validation and credibility
- ✓Board representation and governance
Who Invested in Bioio?
Bioio has attracted investment from 5+ venture capital firms, private equity investors, and strategic partners across 0 funding rounds. These investors have provided a total of $3M in capital to fuel the company's growth.
Why Do Investors Fund Bioio?
Investors are attracted to Bioio due to the company's strong market position, growth potential, and proven business model.
Types of Bioio Investors
Bioio investors typically include a mix of venture capital firms providing growth capital, private equity firms for later-stage funding, strategic corporate investors from related industries, and high-net-worth angel investors. Each investor type brings unique value beyond capital, including industry expertise, strategic partnerships, and operational guidance.
Investor FAQs
How many investors does Bioio have?
Bioio has had 5+ investors participate across its funding rounds. This includes venture capital firms, private equity investors, strategic partners, and angel investors.
Who are the lead investors in Bioio?
Lead investors typically invest the largest amounts and often take board seats. For detailed information about Bioio's lead investors and cap table structure, please contact our team.
Can I become an investor in Bioio?
Accredited investors can purchase Bioio shares on the secondary market through Premier Alternatives. This provides an opportunity to invest in the company before a potential IPO or acquisition event.